Actively Recruiting
Evaluating Autologous Umbilical Cord Tissue Patch for Postnatal Repair of Open Neural Tube Defects in Newborns with Spina Bifida
Led by The University of Texas Health Science Center, Houston · Updated on 2026-09-24
15
Participants Needed
1
Research Sites
235 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the impact of using an autologous umbilical cord tissue patch for closing open neural tube defects in newborns with spina bifida. The study aims to assess successful defect closure, enlargement of the spinal canal, and reduction of inflammatory tissue response compared to past cases. This trial is sponsored by The University of Texas Health Science Center in Houston and focuses on treatment shortly after birth. The intervention involves harvesting the umbilical cord tissue at delivery and processing it in a sterile environment to create a dural patch. This patch is then used to cover and close the spinal cord defect within a few hours after birth, with surgery occurring within the first 24 hours of life. The study follows a single group design where all participants receive this procedure. Participants will be newborns diagnosed prenatally with an open neural tube defect. Researchers will monitor wound healing and check for complications like wound opening or cerebrospinal fluid leakage at one month and one year post-operation. They will also assess neurological function and the presence of tethered cord syndrome at various intervals up to five years. The study involves regular follow-ups to evaluate safety and long-term outcomes, with total participation potentially lasting several years.
CONDITIONS
Brief Title
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
Research Team
S
Stephen Fletcher, DO
C
Caroline Doughty
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here